The Clinic for Eye Diseases at the University Clinical Center Tuzla (UKC Tuzla) has introduced faricimab, an innovative drug, into routine clinical use. Faricimab represents the latest therapeutic option for treating conditions such as neovascular (wet) age-related macular degeneration and diabetic macular edema. It is the first dual-inhibitory monoclonal antibody that targets two key pathological…
Details
The Government of Tuzla Canton has allocated approximately 1.4 million KM over the past year for the purchase of state-of-the-art medical equipment for the Clinic for Ear, Nose and Throat Diseases and Head and Neck Surgery at the University Clinical Center Tuzla (UKC Tuzla). This investment has enabled the procurement of devices that significantly enhance…
Details
The University Clinical Center Tuzla (UKC Tuzla) has implemented a new reverse osmosis system at the Clinic for Internal Diseases, Department of Nephrology, Hemodialysis, and Transplantation. Worth 280,000 KM (excluding VAT), the system was accompanied by the adaptation of the treatment space, significantly improving both technical and hygienic conditions for hemodialysis. Reverse osmosis is an…
Details
As part of its continuous efforts to modernize and enhance healthcare services, the University Clinical Center Tuzla (UKC Tuzla) consistently invests in state-of-the-art medical equipment and professional staff training. One of the latest advancements is the acquisition of a modern EBUS bronchoscope for the Clinic for Pulmonary Diseases, made possible with the support of the…
Details
The University Clinical Center Tuzla (UKC Tuzla) continues to advance in the application of modern medical procedures, enabling patients to receive treatment at the level of leading European centers without the need to travel abroad. At the Clinic for Invasive Cardiology, a new heart valve was successfully implanted using a minimally invasive procedure performed through…
Details